Results 71 to 80 of about 6,941 (175)

HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma

open access: yesPapillomavirus Research, 2018
Vulvar carcinoma is the fourth most common gynecological malignancy. Two separate carcinogenic pathways are suggested, where one is associated with the human papillomavirus (HPV) and HPV16 the most common genotype.The aim of this study was to evaluate ...
Gabriella Lillsunde Larsson   +4 more
doaj   +1 more source

Lichenoid vulvar disease: A review

open access: yesInternational Journal of Women's Dermatology, 2017
Vulvar dermatoses are common, potentially debilitating conditions that can be seen by a variety of medical specialists. Lichenoid vulvar diseases, namely lichen sclerosus (LS), lichen planus (LP), and lichen simplex chronicus (LSC), can all negatively ...
R. Fruchter, BA   +2 more
doaj   +1 more source

Scrotal squamous cell carcinoma: Two HPV‐negative cases with probable UV‐ induced pathogenesis

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Daniel Craus   +7 more
wiley   +1 more source

Active surveillance of cervical intraepithelial neoplasia and adverse pregnancy outcomes: A register‐based cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2097-2103, October 2026.
Active surveillance for cervical intraepithelial neoplasia grade 2 is not associated with increased risks of adverse pregnancy outcomes compared to large loop excision of the transformation zone. Abstract Introduction Previous studies have suggested that human papillomavirus (HPV) and HPV‐related disease may be associated with increased risk of adverse
Kirstine Kold Katholm   +6 more
wiley   +1 more source

Two Distinct Pathways to Development of Squamous Cell Carcinoma of the Vulva

open access: yesJournal of Skin Cancer, 2011
Squamous cell carcinoma (SCC) accounts for approximately 95% of the malignant tumors of the vaginal vulva and is mostly found in elderly women. The future numbers of patients with vulvar SCC is expected to rise, mainly because of the proportional ...
Yutaka Ueda   +5 more
doaj   +1 more source

HPV‐Related Cancers in Solid Organ Transplant Recipients: A Nationwide Danish Cohort Study

open access: yesInternational Journal of Cancer, Volume 159, Issue 6, Page 1432-1439, 15 September 2026.
Solid organ transplant recipients (SOTRs) face chronic immunosuppression, leaving them susceptible to viral infections. Of particular concern is persistent infection with human papillomavirus (HPV), which presents a significant cancer risk. This nationwide Danish cohort study estimated cancer risk in SOTRs using health registry data.
Signe Timm   +7 more
wiley   +1 more source

Concurrent Occurrence of Rectal Adenocarcinoma and Vulvar Keratinizing Squamous Cell Carcinoma: Case Report and Literature Review

open access: yesLietuvos Chirurgija
Introduction. Vulvar carcinoma is a rare malignancy, whereas rectal cancer is a more common oncological condition. However, the simultaneous occurrence of these two diseases is exceptionally rare. Case presentation.
Odeta Laukaitytė   +3 more
doaj   +1 more source

Vulvar Metastasis of Cervical Squamous Cell Carcinoma

open access: yesActa Médica Portuguesa, 2017
N/A.
Joana Moreira-Barros, Kuan-Gen Huang
openaire   +2 more sources

The tell-tale heart: A case of recurrent vulvar carcinoma with cardiac metastasis and review of literature

open access: yesGynecologic Oncology Reports, 2017
A 50-year-old female was diagnosed with vulvar cancer treated with left partial vulvectomy and bilateral lymphadenectomy. Ten months after her surgery, she presented with increased labial swelling, pain and discharge.
Syed Imran Mustafa Jafri   +4 more
doaj   +1 more source

Trop2-expression in primary vulvar squamous cell carcinoma

open access: yesGynecologic Oncology
Vulvar squamous cell carcinoma (VSCC) is a rare malignant disease but with increasing incidence. Therapeutic options are generally limited to surgery and radio-(chemo)therapy. New strategies for therapy are lacking. Trophoblast cell surface antigen 2 (Trop2) is a new target being used in different tumor entities.
Frederik A, Stuebs   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy